Macular telangiectasia type 2, also known as MacTel, is a rare eye disease that can lead to vision loss. Although MacTel rarely leads to total blindness, it does cause a decline of sharp central ...

No extract is available for articles shorter than 400 words.

Beth earned a B.S. in Business Administration in Marketing from Miami University. About Macular Telangiectasia Type 2 (MacTel) Macular Telangiectasia Type 2 (MacTel), or idiopathic macular ...

1 Nottingham Children's Hospital, National Paediatric Ataxia Telangiectasia Clinic, QMC, Nottingham, UK Background and aims Ataxia telangiectasia (A-T) is a rare progressive, multisystem genetic ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose ...

In this role, Beth will lead the commercial organization, including preparing for the U.S. launch of ENCELTO TM (revakinagene taroretcel-lwey), the first and only approved treatment for adults with ...

Amvuttra (vutrisiran) Transthyretin-directed small interfering RNA therapeutic Treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis in adults to reduce ...

Amvuttra (vutrisiran) Transthyretin-directed small interfering RNA therapeutic Treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis in adults to reduce ...

Usually, you do not need to worry about a nosebleed (epistaxis). Most nosebleeds stop after a few minutes with at-home care, like pinching your nose and leaning forward. A nosebleed can be a serious ...